Abbokinase

A proprietary formulation of urokinase, a thrombolytic that activates the fibrinolysis by increasing plasmin production from plasminogen, thereby degrading fibrin clots, fibrinogen, and other clotting factors.

Mentioned in

References in periodicals archive

Update on Abbokinase. Accessed at http://www.fda.gov/cber /infosheets/abb12599.htm.

The Efficacy of Reteplase in the Treatment of Thrombosed Hemodialysis Venous Catheters

"Our two drugs are now poised to fill an unmet medical need caused by the disappearance of Abbott's brands of urokinase (Abbokinase and OpenCath) from the market," says William J.

Court's dismissal of counterclaim opens door for Microbix into United States market for generic urokinase

Urokinase is commercially available in dosages of 5,000 units/lmL and 9,000 units/1.8 mL vials (Abbokinase Open-Cath, Abbott Laboratories, North Chicago, IL).

Central Venous Catheter Occlusion: Successful Management Strategies

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.